Protocol Ledger

NCT07414745 · Phase III · RECRUITING

MDT-0123 Japan Study

Interventional Phase III clinical trial protocol NCT07414745 sponsored by Medtronic Spinal and Biologics in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-04-24 Enrollment: 140 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07414745
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)140 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07414745
Protocol FieldVerified Registry Value
NCT IdentifierNCT07414745
Consolidated Lead SponsorMedtronic Spinal and Biologics
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment140 participants (ESTIMATED)
Registered Start Date2026-04-24
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07414745
Hospital Research SiteLocationSite Profile
Kobe University HospitalKobe, JapanOpen Hospital Dossier ->
Keio University HospitalShinjuku-ku, JapanOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI